In vitro studies on the mechanisms of oxaliplatin resistance.
about
Pharmacologic resistance in colorectal cancer: a reviewMicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.Review of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatmentsReduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines.Xeroderma pigmentosum group a protein and chemotherapy resistance in human germ cell tumors.Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsmiR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinaseResistance to platinum-based chemotherapy in lung cancer cell lines.Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variantsOxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance.Molecular mechanisms of resistance and toxicity associated with platinating agents.Thermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells.{(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo.Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29.HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway.Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.Effects of oxaliplatin on mouse myenteric neurons and colonic motility.Dysregulation of purine nucleotide biosynthesis pathways modulates cisplatin cytotoxicity in Saccharomyces cerevisiae.Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cellsMice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuliUrsolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer.Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin.The paradigm of mutant p53-expressing cancer stem cells and drug resistance.Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients.Cisplatin resistance in human cervical, ovarian and lung cancer cells.Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma.Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer.Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective.WBSCR22 confers oxaliplatin resistance in human colorectal cancer.Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression.
P2860
Q26769850-19E08209-CAA7-425F-83E4-5A03603B961AQ27853222-7C06D652-958F-4B24-AF83-42FF05508892Q28082382-132EB449-9AB4-47BD-9657-5174EF0DA266Q30760649-3FAE800B-C869-4F5B-A155-10862FA3B16FQ33194000-AB778F9A-74ED-4962-960C-CDCE2660C8F1Q33264666-6B581D55-4043-4591-8F16-6A1B50362E87Q33591648-8A0F5503-FFF2-4312-9B92-AB7E43AC43A4Q34008793-A3473CDB-7BA1-457D-B71A-90539DCE75ACQ34013539-47229D36-9EA5-4453-BBDB-0846ECF60D87Q34214006-7457A18F-EA4C-4D1E-8DD3-84FE769B1FFCQ34525850-BE01DE36-5AA8-49CB-AAB9-9ADD462F9F1FQ35572923-3743DF1F-DA28-4F40-8C84-54F5E0E279C3Q35758048-F54AC2D1-45FF-44C5-98C2-83B6D43EB3C0Q35761696-9F131C86-5696-4579-8487-41A14EACF560Q36031384-5A0FD309-FF7B-40D5-8B9A-0EC12CD32C95Q36097117-048AA522-56B0-4F15-82F6-871B110CDC09Q36212999-CEC3706E-F682-4EA8-A8A1-7D03D6C76532Q36610915-334505F5-64DA-4C6F-9894-3FF24DB4FAC8Q36676211-18B18F07-B0DF-4F1C-A51C-007194A82ACCQ36952570-CC8BD31F-39B7-4735-81BD-AF130386B1F2Q36985163-216AD5E9-3182-4F70-B6FF-E6365FD8033FQ37127360-1A657397-40D9-49C0-B067-2E48973AC8D2Q37165886-6FEFB294-488A-4F3D-AA4A-4E90274C1DF7Q37310461-52E9F8D5-5FB8-45E9-A4A5-42F420D919A6Q38198487-97553DE1-1E7B-424F-A143-F5E30423BEB5Q38328481-B1467E8F-DD3C-4C04-9DBD-C29B64B3D81EQ38653846-C0724136-2B66-4268-A36D-DFCEEC261FF8Q38719571-8842C510-75E9-4FAE-8B4F-EE6B76273B0BQ38720813-D2712AEA-813C-415C-AFDD-2968E5E3EF7EQ38764239-9DC52D8C-6AD6-44F3-B31D-32B013E99803Q38835268-D97445C5-E69E-42FF-8DC5-F75A8D748CDDQ38884442-3A3A50A6-8F64-46D2-BD6B-F22973C4155FQ39235908-2C87BB7B-12D4-43EB-AEBB-C5F1A8C62F37Q39695089-F5CE2BE7-6A21-4F74-A24A-72A54E0738B9Q39986942-346CA30D-D6DF-4785-8FCD-A4596DF94B64Q40698597-2530A8EB-AD08-4DAD-9141-8B6A6221C4FAQ41782195-6E596BBA-18AE-4713-8BD6-304E5602CD39Q44242635-955769B1-D58B-41BC-BBAF-54A177369259Q46262349-C8904928-046B-4E66-A7E6-36C0F23B873DQ47106149-0224AEC8-F2AE-4029-A52A-7AB16AA10C92
P2860
In vitro studies on the mechanisms of oxaliplatin resistance.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
In vitro studies on the mechanisms of oxaliplatin resistance.
@ast
In vitro studies on the mechanisms of oxaliplatin resistance.
@en
type
label
In vitro studies on the mechanisms of oxaliplatin resistance.
@ast
In vitro studies on the mechanisms of oxaliplatin resistance.
@en
prefLabel
In vitro studies on the mechanisms of oxaliplatin resistance.
@ast
In vitro studies on the mechanisms of oxaliplatin resistance.
@en
P2093
P356
P1476
In vitro studies on the mechanisms of oxaliplatin resistance.
@en
P2093
Bolanowska-Higdon W
Pendyala L
Zdanowicz J
P2888
P304
P356
10.1007/S002800100363
P577
2001-11-01T00:00:00Z
P6179
1046538472